Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing Article

cited authors

  • Galbraith, Kristyn; Vasudevaraja, Varshini; Serrano, Jonathan; Shen, Guomiao; Tran, Ivy; Abdallat, Nancy; Wen, Mandisa; Patel, Seema; Movahed-Ezazi, Misha; Faustin, Arline; Spino-Keeton, Marissa; Roberts, Leah Geiser; Maloku, Ekrem; Drexler, Steven A.; Liechty, Benjamin L.; Pisapia, David; Krasnozhen-Ratush, Olga; Rosenblum, Marc; Shroff, Seema; Boue, Daniel R.; Davidson, Christian; Mao, Qinwen; Suchi, Mariko; North, Paula; Hopp, Amanda; Segura, Annette; Jarzembowski, Jason A.; Parsons, Lauren; Johnson, Mahlon D.; Mobley, Bret; Samore, Wesley; McGuone, Declan; Gopal, Pallavi P.; Canoll, Peter D.; Horbinski, Craig; Fullmer, Joseph M.; Farooqui, Midhat S.; Gokden, Murat; Wadhwani, Nitin R.; Richardson, Timothy E.; Umphlett, Melissa; Tsankova, Nadejda M.; DeWitt, John C.; Sen, Chandra; Placantonakis, Dimitris G.; Pacione, Donato; Wisoff, Jeffrey H.; Teresa Hidalgo, Eveline; Harter, David; William, Christopher M.; Cordova, Christine; Kurz, Sylvia C.; Barbaro, Marissa; Orringer, Daniel A.; Karajannis, Matthias A.; Sulman, Erik P.; Gardner, Sharon L.; Zagzag, David; Tsirigos, Aristotelis; Allen, Jeffrey C.; Golfinos, John G.; Snuderl, Matija

Publication Date

  • January 1, 2023

webpage

published in

category

keywords

  • DNA methylation
  • central nervous system tumors
  • guidelines
  • molecular
  • tumor classification

volume

  • 5

issue

  • 1